RESUMEN
Cerebrovascular accident (CVA) is one of the leading causes of death and disability worldwide, as well as a major financial burden for health care systems. CVA rodent models provide experimental support to determine possible in vivo therapies to reduce brain injury and consequent sequelae. This study analyzed nociceptive, motor, cognitive and mood functions in mice submitted to distal middle cerebral artery (DMCA) occlusion. Male C57BL mice (n = 8) were randomly allocated to control or DMCA groups. Motor function was evaluated with the tests: grip force, rotarod and open field; and nociceptive threshold with von Frey and hot plate assessments. Cognitive function was evaluated with the inhibitory avoidance test, and mood with the tail suspension test. Evaluations were conducted on the seventh- and twenty-eighth-day post DMCA occlusion to assess medium- and long-term effects of the injury, respectively. DMCA occlusion significantly decreases muscle strength and spontaneous locomotion (p < 0.05) both medium- and long term; as well as increases immobility in the tail-suspension test (p < 0.05), suggesting a depressive-type behavior. However, DMCA occlusion did not affect nociceptive threshold nor cognitive functions (p > 0.05). These results suggest that, medium- and long-term effects of DMCA occlusion include motor function impairments, but no sensory dysfunction. Additionally, the injury affected mood but did not hinder cognitive function.
RESUMEN
Fibromyalgia (FM) has an inflammatory component, as elevated serum levels of inflammatory biomarkers are associated with its diagnosis. Treatments decreased pain, body temperature, improved quality of life and reduced serum levels of IL-6 in both groups; however, these beneficial effects were more pronounced in aquatic exercise (AE)â¯+â¯Far-Infrared (FIR) group. The findings of the present study suggest that the association of AE to FIR increases the benefits of aquatic exercise in patients with FM.
Asunto(s)
Citocinas/sangre , Ejercicio Físico/fisiología , Fibromialgia/sangre , Fibromialgia/terapia , Rayos Infrarrojos/uso terapéutico , Manejo del Dolor/métodos , Adulto , Anciano , Biomarcadores/sangre , Cerámica , Método Doble Ciego , Ejercicio Físico/psicología , Femenino , Fibromialgia/psicología , Humanos , Masculino , Persona de Mediana Edad , Dolor/sangre , Dolor/psicología , Proyectos Piloto , Calidad de Vida/psicología , PiscinasRESUMEN
BACKGROUND: Neuropathic pain is relatively common and occurs in approximately 6-8% of the population. It is associated with allodynia and hyperalgesia. Thus, non-pharmacological treatments, such as transcranial direct current stimulation (tDCS) may be useful for relieving pain. OBJECTIVES: This study aimed to investigate the antiallodynic effect of tDCS in a mice model of neuropathic pain, and the underlying neurotransmission systems that could drive these effects. METHODS: Male, Swiss mice, weighing 25-35â¯g, were subjected to partial sciatic nerve ligation (PSNL). Allodynia was assessed using a Von Frey filament (0.6â¯g). First, the behavioral time-course of these mice was assessed after 5, 10, 15 and 20â¯min of tDCS (0.5â¯mA). Second, the mice that underwent PSNL were assigned to either the tDCS (0.5â¯mA, 15â¯min) or tDCS sham group, and further assigned to receive either saline or a drug (i.e., naloxone, yohimbine, a-methyl-p-tyrosine, q-chlorophenylalanine methyl ester, caffeine, 1,3-dipropyl-8-cyclopentylxanthine, AM281, AM630, flumazenil, MK-801, or lidocaine). RESULTS: The antiallodynic effect of tDCS lasted 2â¯h and 4â¯h, after 10â¯min and 15 or 20â¯min of treatment, respectively (Pâ¯<â¯.001, Pâ¯<â¯.01, and Pâ¯<â¯.05, respectively). The antiallodynic effect of tDCS was associated with all the systems that were analyzed, i.e., the opioidergic (Pâ¯<â¯.01), adenosinergic (Pâ¯<â¯.001), serotonergic (Pâ¯<â¯.01), noradrenergic (Pâ¯<â¯.001), cannabinoid (Pâ¯<â¯.001), GABAergic, and glutamatergic (Pâ¯<â¯.001) systems. Lidocaine did not reverse the antiallodynic effect of tDCS (Pâ¯>â¯.05). CONCLUSION: The antiallodynic effect of tDCS was associated with different neurotransmitters systems; the duration of these after-effects depended on the time exposure to tDCS.
Asunto(s)
Hiperalgesia/etiología , Hiperalgesia/terapia , Neuralgia/complicaciones , Neuralgia/terapia , Umbral del Dolor/fisiología , Estimulación Transcraneal de Corriente Directa/métodos , Antagonistas del Receptor de Adenosina A1/uso terapéutico , Animales , Cafeína/uso terapéutico , Estimulantes del Sistema Nervioso Central/uso terapéutico , Modelos Animales de Enfermedad , Maleato de Dizocilpina/uso terapéutico , Antagonistas de Aminoácidos Excitadores/uso terapéutico , Flumazenil/uso terapéutico , Moduladores del GABA/uso terapéutico , Masculino , Ratones , Morfolinas/uso terapéutico , Naloxona/uso terapéutico , Antagonistas de Narcóticos/uso terapéutico , Estimulación Física/efectos adversos , Pirazoles/uso terapéutico , Xantinas/uso terapéuticoRESUMEN
This study evaluated the effects of continuous and interval running on a treadmill on mechanical hyperalgesia in an animal model of chronic postischemia pain and analyzed the mechanism of action of this effect. Different groups of male Swiss mice with chronic postischemia pain, induced by 3 hours of paw ischemia followed by reperfusion, ran on the treadmill in different protocols-the speed (10, 13, 16, or 19 m/min), duration (15, 30, or 60 minutes), weekly frequency (3 or 5 times), weekly increase in continuous and interval running speed-were tested. Mechanical hyperalgesia was evaluated by von Frey filament 7, 14, and 21 days after paw ischemia followed by reperfusion. On day 11 after paw ischemia followed by reperfusion and after 5 days of continuous and interval running, concentrations of cytokines, oxidative stress parameters, and extracellular signal-regulated kinase 1/2 and AKT 1/2/3 expression in the spinal cord were measured. The results showed that continuous running has an antihyperalgesic effect that depends on intensity and volume. Interval running has a longer-lasting antihyperalgesic effect than continuous running. The antihyperalgesic effect depends on intensity and volume in continuous running, and increasing speed maintains the antihyperalgesic effect in both protocols. In the spinal cord, both runs decreased tumor necrosis factor-α and interleukin-6 levels and increased interleukin-10. Both running protocols reduced oxidative damage in the spinal cord. Only interval running had lower concentrations of phosphorylated extracellular signal-regulated kinase 1/2 in the spinal cord. Interval running presented a great antihyperalgesic potential with more promising results than continuous running, which may be owing to the fact that the interval running can activate different mechanisms from those activated by continuous running. PERSPECTIVE: A minimum of .5-hour sessions of moderate to high intensity ≥3 times a week are essential parameters for continuous and interval running-induced analgesia. However, interval running was shown to be more effective than continuous running and can be an important adjuvant treatment to chronic pain.